GALNT10
Polypeptide N-acetylgalactosaminyltransferase 10
Also known as: GalNAc-T10, GLT10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86SR1
- Gene
- GALNT10
- Ensembl
- ENSG00000164574
- Chromosome
- 5
- Canonical length
- 603 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Plasma membrane
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the GalNAc polypeptide N-acetylgalactosaminyltransferases. These enzymes catalyze the first step in the synthesis of mucin-type oligosaccharides. These proteins transfer GalNAc from UDP-GalNAc to either serine or threonine residues of polypeptide acceptors. The protein encoded by this locus may have increased catalytic activity toward glycosylated peptides compared to activity toward non-glycosylated peptides.[provided by RefSeq, Apr 2010]
Canonical amino-acid sequenceUniProt
603 residues, UniProt reviewed canonical sequence.
>Q86SR1|GALNT10
1 MRRKEKRLLQ AVALVLAALV LLPNVGLWAL YRERQPDGTP GGSGAAVAPA AGQGSHSRQK
61 KTFFLGDGQK LKDWHDKEAI RRDAQRVGNG EQGRPYPMTD AERVDQAYRE NGFNIYVSDK
121 ISLNRSLPDI RHPNCNSKRY LETLPNTSII IPFHNEGWSS LLRTVHSVLN RSPPELVAEI
181 VLVDDFSDRE HLKKPLEDYM ALFPSVRILR TKKREGLIRT RMLGASVATG DVITFLDSHC
241 EANVNWLPPL LDRIARNRKT IVCPMIDVID HDDFRYETQA GDAMRGAFDW EMYYKRIPIP
301 PELQKADPSD PFESPVMAGG LFAVDRKWFW ELGGYDPGLE IWGGEQYEIS FKVWMCGGRM
361 EDIPCSRVGH IYRKYVPYKV PAGVSLARNL KRVAEVWMDE YAEYIYQRRP EYRHLSAGDV
421 AVQKKLRSSL NCKSFKWFMT KIAWDLPKFY PPVEPPAAAW GEIRNVGTGL CADTKHGALG
481 SPLRLEGCVR GRGEAAWNNM QVFTFTWRED IRPGDPQHTK KFCFDAISHT SPVTLYDCHS
541 MKGNQLWKYR KDKTLYHPVS GSCMDCSESD HRIFMNTCNP SSLTQQWLFE HTNSTVLEKF
601 NRNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GALNT10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- ovary: 52 nTPM
- choroid plexus: 42 nTPM
- cervix: 23 nTPM
- stomach: 21 nTPM
- bone marrow: 18 nTPM
- blood vessel: 16 nTPM
Single-cell type
- pituicytes/fscs: 783 nCPM
- choroid plexus epithelial cells: 381 nCPM
- megakaryocyte-erythroid progenitors: 305 nCPM
- erythrocyte progenitors: 303 nCPM
- pituitary stem cells: 284 nCPM
- granulosa cells: 271 nCPM
Immune cell
- gdT-cell: 3.1 nTPM
- MAIT T-cell: 2.8 nTPM
- eosinophil: 2.4 nTPM
- neutrophil: 2.4 nTPM
- basophil: 2.1 nTPM
- naive B-cell: 2.1 nTPM
Brain region
- choroid plexus: 64 nTPM
- medulla oblongata: 28 nTPM
- basal ganglia: 24 nTPM
- midbrain: 24 nTPM
- thalamus: 24 nTPM
- pons: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.53
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GALNT10 as an antibody target. Whether an autoantibody or antibody against GALNT10 could matter depends on whether native GALNT10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GALNT10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GALNT10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...